Harrow (HROW) Enterprise Value (2010 - 2026)
Harrow (HROW) posted quarterly Enterprise Value of -$95.0 million for Q1 2026, down 41.62% year-over-year from -$162.7 million in Q1 2025, and down 29.63% quarter-over-quarter from -$73.3 million in Q4 2025.
Harrow (HROW) Enterprise Value (2010 - 2026) Analysis & Trends
Harrow's Enterprise Value history runs 17 years deep, the most recent figure standing at -$95.0 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 41.62% year-over-year to -$95.0 million; the TTM figure through Mar 2026 stood at -$95.0 million (down 41.62% YoY), while the FY2025 annual figure was -$73.3 million, down 53.95% from the prior year.
- Enterprise Value for Q1 2026 stood at -$95.0 million, down from -$73.3 million in the prior quarter.
- The five-year high for Enterprise Value was -$27.2 million in Q1 2023, with the low at -$102.2 million in Q4 2022.
- The 5-year median for Enterprise Value is -$71.3 million (2024), against an average of -$64.8 million.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value slumped 642.75% in 2022, then soared 46.54% in 2023.
- Harrow's Enterprise Value stood at -$102.2 million in 2022, then rose by 18.68% to -$83.1 million in 2023, then soared by 42.73% to -$47.6 million in 2024, then plunged by 53.95% to -$73.3 million in 2025, then decreased by 29.63% to -$95.0 million in 2026.
- Business Quant data shows HROW's Enterprise Value at -$95.0 million in Q1 2026, -$73.3 million in Q4 2025, and -$74.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | -164.00 Mn |
| 10 | Harrow | 1.55 Bn | 1.46 Bn | 50.36 Mn | -84.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -84.24 Mn |
| Mar 31, 2026 | -95.00 Mn |
| Dec 31, 2025 | -73.28 Mn |
| Sep 30, 2025 | -74.65 Mn |
| Jun 30, 2025 | -53.32 Mn |
| Mar 31, 2025 | -67.08 Mn |
| Dec 31, 2024 | -47.60 Mn |
| Sep 30, 2024 | -72.96 Mn |
| Jun 30, 2024 | -71.32 Mn |
| Mar 31, 2024 | -76.33 Mn |
| Dec 31, 2023 | -83.12 Mn |
| Sep 30, 2023 | -74.23 Mn |
| Jun 30, 2023 | -30.03 Mn |
| Mar 31, 2023 | -27.23 Mn |
| Dec 31, 2022 | -102.21 Mn |
| Sep 30, 2022 | -49.48 Mn |
| Jun 30, 2022 | -51.99 Mn |
| Mar 31, 2022 | -50.95 Mn |
| Dec 31, 2021 | -51.03 Mn |
| Sep 30, 2021 | -68.20 Mn |